TY  - GEN
AU  - Bradley,John D
AU  - Dmitrienko,Alexei A
AU  - Kivitz,Alan J
AU  - Gluck,Oscar S
AU  - Weaver,Arthur L
AU  - Wiesenhutter,Craig
AU  - Myers,Stephen L
AU  - Sides,Gregory D
TI  - A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis
SN  - 0315-162X
PY  - 2005///0719
KW  - Acetates
KW  - adverse effects
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Animals
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - drug therapy
KW  - Double-Blind Method
KW  - Enzyme Inhibitors
KW  - Female
KW  - Humans
KW  - Indoles
KW  - Keto Acids
KW  - Middle Aged
KW  - Phospholipases A
KW  - antagonists & inhibitors
KW  - Phospholipases A2
KW  - Placebos
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
ER  -